VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+34.89%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$368M
AUM Growth
+$18.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
553
New
Increased
Reduced
Closed

Top Buys

1
+$2.17M
2
+$2.09M
3
+$2.03M
4
AMAT icon
Applied Materials
AMAT
+$2.01M
5
LVS icon
Las Vegas Sands
LVS
+$2.01M

Top Sells

1
+$2.5M
2
+$2.43M
3
+$2.05M
4
MS icon
Morgan Stanley
MS
+$2.04M
5
ATO icon
Atmos Energy
ATO
+$2.02M

Sector Composition

1 Healthcare 26.73%
2 Financials 22.73%
3 Technology 18.16%
4 Industrials 8.89%
5 Consumer Discretionary 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVTX icon
151
Travere Therapeutics
TVTX
$4.1B
$750K 0.2%
19,620
-10,125
HALO icon
152
Halozyme
HALO
$8.21B
$739K 0.2%
10,984
+2,836
PFLT icon
153
PennantPark Floating Rate Capital
PFLT
$860M
$739K 0.2%
79,701
-13,142
PNNT
154
Pennant Park Investment Corp
PNNT
$276M
$734K 0.2%
123,166
-15,952
EXEL icon
155
Exelixis
EXEL
$12.8B
$733K 0.2%
16,716
+6,079
NUVB icon
156
Nuvation Bio
NUVB
$1.64B
$726K 0.2%
81,068
+18,202
CSWC icon
157
Capital Southwest
CSWC
$1.44B
$724K 0.2%
32,682
-7,479
CION icon
158
CION Investment
CION
$338M
$720K 0.2%
74,429
-22,157
BTX
159
BlackRock Technology and Private Equity Term Trust
BTX
$1.03B
$718K 0.2%
108,899
-25,608
REGN icon
160
Regeneron Pharmaceuticals
REGN
$75.5B
$711K 0.19%
921
+69
SNDX icon
161
Syndax Pharmaceuticals
SNDX
$1.82B
$705K 0.19%
33,549
+22,885
BCRX icon
162
BioCryst Pharmaceuticals
BCRX
$2.43B
$704K 0.19%
90,278
+47,548
AMGN icon
163
Amgen
AMGN
$182B
$704K 0.19%
2,150
+655
TBPH icon
164
Theravance Biopharma
TBPH
$859M
$704K 0.19%
37,611
-4,273
NVAX icon
165
Novavax
NVAX
$1.54B
$699K 0.19%
104,019
+41,866
GILD icon
166
Gilead Sciences
GILD
$164B
$697K 0.19%
5,675
+1,709
BBIO icon
167
BridgeBio Pharma
BBIO
$13.6B
$696K 0.19%
9,093
-2,115
MDGL icon
168
Madrigal Pharmaceuticals
MDGL
$12B
$695K 0.19%
1,194
-301
KURA icon
169
Kura Oncology
KURA
$865M
$695K 0.19%
66,870
+49,785
GAIN icon
170
Gladstone Investment Corp
GAIN
$660M
$691K 0.19%
49,495
-20,759
BIIB icon
171
Biogen
BIIB
$28.3B
$690K 0.19%
3,923
+564
MFIC icon
172
MidCap Financial Investment
MFIC
$907M
$689K 0.19%
60,236
-9,997
KRYS icon
173
Krystal Biotech
KRYS
$9.21B
$688K 0.19%
2,792
-375
AUPH icon
174
Aurinia Pharmaceuticals
AUPH
$2.04B
$688K 0.19%
43,117
-10,880
TARS icon
175
Tarsus Pharmaceuticals
TARS
$2.8B
$688K 0.19%
8,399
-2,453
5 6
7
8 9